Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amyopathic dermatomyositis.

Bouchra Saoud1, Fadoua Allali, Najia Hajjaj Hassouni

  • 1Rheumatology B Department, El Ayachi Hospital, Rabat-Salé Teaching Hospitals, Morocco.

Joint Bone Spine
|October 29, 2005
PubMed
Summary

Amyopathic dermatomyositis (ADM) presents with skin rashes but no muscle weakness, a rare condition. While ADM often has a good prognosis, developing pulmonary fibrosis can worsen outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors Determining the Switch of the First Biological Treatment in Spondyloarthritis: Data from the RBSMR Registry.

Current rheumatology reviews·2026
Same author

Rehabilitation and return to activity after platelet-rich plasma injections in chronic tendinopathies: Consensus from international experts.

PM & R : the journal of injury, function, and rehabilitation·2026
Same author

Non-steroidal Anti-inflammatory Drug Misuse: Knowledge, Attitudes and Practices of Community Pharmacists in Morocco.

Cureus·2025
Same author

What are the characteristics of paradoxical effects in the Biotherapies Registry of the Moroccan Society of Rheumatology?

Reumatologia·2025
Same author

Sedentary behavior and physical activity preferences in patients with knee osteoarthritis: insights from a cross-sectional study.

Reumatismo·2025
Same author

Tuberculosis Under Biotherapy in Patients with Spondyloarthritis: Data from the Moroccan Biotherapy Registry (RBSMR) during 3 Years of Follow Up.

Mediterranean journal of rheumatology·2025

Area of Science:

  • Rheumatology
  • Dermatology
  • Pulmonology

Background:

  • Amyopathic dermatomyositis (ADM) is a rare subset of dermatomyositis (DM) characterized by skin manifestations without clinical muscle involvement.
  • Distinguishing ADM from classic DM is crucial for prognosis and management.

Observation:

  • A 64-year-old woman presented with a 2.5-year history of polyarthritis and DM-suggestive skin lesions (heliotrope edema, Gottron's papules, facial rash).
  • Muscle enzyme assays, electromyography, and biopsies were normal, confirming the absence of myositis.
  • Early pulmonary fibrosis was detected despite the lack of muscle symptoms and negative tumor workup.

Findings:

  • ADM is an uncommon condition, potentially an abortive form of DM with a generally favorable prognosis.
  • The risk of malignancy in ADM may be lower than in classic DM.
  • Pulmonary fibrosis, though uncommon, can significantly complicate the clinical course and prognosis of ADM.

Implications:

  • This case highlights the importance of monitoring for pulmonary complications even in ADM patients without muscle disease.
  • Early detection of lung fibrosis in ADM is critical for timely intervention and improved patient outcomes.
  • Understanding the spectrum of ADM, including its potential for pulmonary involvement, refines diagnostic and therapeutic strategies.

Related Experiment Videos